Literature DB >> 16510162

Increased FasL expression correlates with apoptotic changes in granulocytes cultured with oxidized clozapine.

Zaheed Husain1, Ingrid Almeciga, Julio C Delgado, Olga P Clavijo, Januario E Castro, Viviana Belalcazar, Clara Pinto, Joaquin Zuñiga, Viviana Romero, Edmond J Yunis.   

Abstract

Clozapine has been associated with a 1% incidence of agranulocytosis. The formation of an oxidized intermediate clozapine metabolite has been implicated in direct polymorphonuclear (PMN) toxicity. We utilized two separate systems to analyze the role of oxidized clozapine in inducing apoptosis in treated cells. Human PMN cells incubated with clozapine (0-10 microM) in the presence of 0.1 mM H2O2 demonstrated a progressive decrease of surface CD16 expression along with increased apoptosis. RT-PCR analysis showed decreased CD16 but increased FasL gene expression in clozapine-treated PMN cells. No change in constitutive Fas expression was observed in treated cells. In HL-60 cells induced to differentiate with retinoic acid (RA), a similar increase in FasL expression, but no associated changes in CD16 gene expression, was observed following clozapine treatments. Our results demonstrate increased FasL gene expression in oxidized clozapine-induced apoptotic neutrophils suggesting that apoptosis in granulocytes treated with clozapine involves Fas/FasL interaction that initiates a cascade of events leading to clozapine-induced agranulocytosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16510162     DOI: 10.1016/j.taap.2006.01.008

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  9 in total

1.  Safety and tolerability of antipsychotic polypharmacy.

Authors:  Juan A Gallego; Jimmi Nielsen; Marc De Hert; John M Kane; Christoph U Correll
Journal:  Expert Opin Drug Saf       Date:  2012-05-08       Impact factor: 4.250

2.  Neutrophil expression of Fas ligand and perforin directs effector CD8 T cell infiltration into antigen-challenged skin.

Authors:  Danielle D Kish; Anton V Gorbachev; Neetha Parameswaran; Neetu Gupta; Robert L Fairchild
Journal:  J Immunol       Date:  2012-07-18       Impact factor: 5.422

3.  Clozapine linked to nanocapsules minimizes tissue and oxidative damage to biomolecules lipids, proteins and DNA in brain of rats Wistar.

Authors:  Angélica Aparecida da Costa Güllich; Ritiéle Pinto Coelho; Bruna Cocco Pilar; Deise Jaqueline Ströher; Leandro Alex Sander Leal Galarça; Simone Machado Vieira; Jacqueline da Costa Escobar Piccoli; Sandra Elisa Haas; Vanusa Manfredini
Journal:  Metab Brain Dis       Date:  2014-10-09       Impact factor: 3.584

Review 4.  Genetics of antipsychotic-induced side effects and agranulocytosis.

Authors:  Nabilah I Chowdhury; Gary Remington; James L Kennedy
Journal:  Curr Psychiatry Rep       Date:  2011-04       Impact factor: 5.285

5.  Clozapine treatment of patients with refractory schizophrenia, concurrent dengue infection and hematological abnormalities: three case reports.

Authors:  Emerson Arcoverde Nunes; Tatiana M N Rezende; Silvio L Morais; José A S Crippa; Serdar M Dursun; Glen B Baker; Jaime E C Hallak
Journal:  Ther Adv Psychopharmacol       Date:  2013-04

6.  Genetic risk of clozapine-induced leukopenia and neutropenia: a genome-wide association study.

Authors:  Jianhua Chen; Ping Yang; Qian Zhang; Ruirui Chen; Peng Wang; Benxiu Liu; Wensheng Sun; Xuemin Jian; Siying Xiang; Juan Zhou; Ningning Li; Ke Wang; Chengwen Gao; Yanqin Wen; Chuanhong Wu; Jinmai Zhang; Yalin Zhao; Qiangzhen Yang; Meihang Li; Robert Stewart; Yuanchao Sun; Dun Pan; Yujuan Niu; Zhuo Wang; Yifeng Xu; Xingwang Li; Lin He; Zhiqiang Li; Yongyong Shi
Journal:  Transl Psychiatry       Date:  2021-06-03       Impact factor: 6.222

7.  Consensus statement on the use of clozapine during the COVID-19 pandemic.

Authors:  Dan Siskind; William G Honer; Scott Clark; Christoph U Correll; Alkomiet Hasan; Oliver Howes; John M Kane; Deanna L Kelly; Robert Laitman; Jimmy Lee; James H MacCabe; Nick Myles; Jimmi Nielsen; Peter F Schulte; David Taylor; Helene Verdoux; Amanda Wheeler; Oliver Freudenreich
Journal:  J Psychiatry Neurosci       Date:  2020-05-01       Impact factor: 6.186

8.  Risperidone-induced reversible neutropenia.

Authors:  Vasanth Kattalai Kailasam; Victoria Chima; Uchechukwu Nnamdi; Kavita Sharma; Kairav Shah
Journal:  Neuropsychiatr Dis Treat       Date:  2017-07-25       Impact factor: 2.570

9.  Late Onset Agranulocytosis with Clozapine Associated with HLA DR4 Responding to Treatment with Granulocyte Colony-stimulating Factor: A Case Report and Review of Literature.

Authors:  Aakanksha Singh; Sandeep Grover; Pankaj Malhotra; Subhash C Varma
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-05-31       Impact factor: 2.582

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.